Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Gerhard Nehmiz |
| Publication date | March 27, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |